CESAVERT 24MG

INDICATIONS: Cesavert is indicated for the treatment of Ménière’s syndrome, characterized by symptoms such as:

• Vertigo
• Tinnitus
• Hearing loss
• Nausea

And for cases of:

• Vestibular neuronitis
• Transient ischemic attack (TIA)
• Vestibular migraine

DOSAGE: The initial treatment is 8 to 16 mg, three times daily. Maintenance doses range from 24 to 48 mg per day (maximum dose), which may be adjusted according to needs after 2 or 3 weeks of treatment. The duration of treatment is 2 to 3 months, depending on the progression of the disease, administered as a continuous or intermittent course.

ADVANTAGES:

• Drug of choice for preventing vertigo attacks
• For diabetic patients with sensorineural hearing loss
• Improves bioavailability in the treatment of schizophrenia when
• combined with MAOIs (selegiline)
• Facilitates precapillary microcirculation
• Direct action on the vestibular nuclei
• Synergistic action on histamine receptors (H1 and H3)